Skip to content
ppharmaranks
Menu

Best Nonergot Dopamine Agonist for parkinson disease

Top-rated pick: Mirapex ER — pharmaranks score 72/100, the highest of the 3 Nonergot Dopamine Agonist drugs used for parkinson disease, ranked by our independent FDA recall-safety score. Compare them with all treatments for parkinson disease or the full Nonergot Dopamine Agonist class. Not medical advice — always consult a professional.

Quick answer: Of the 3 nonergot dopamine agonist drugs we rate for parkinson disease, 2 are available as lower-cost generics, and most are tablet. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for parkinson disease; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Other drug classes for parkinson disease

Top nonergot dopamine agonist for parkinson disease: 1. Mirapex ER · 2. Neupro · 3. Ropinirole Hydrochloride

Best-rated Nonergot Dopamine Agonist for parkinson disease, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$2View →
270/100View →
3Not yet rated$2View →

Full ranking · 3 drugs

Frequently asked

What is the best nonergot dopamine agonist for parkinson disease?
By our independent recall-safety rating — not an efficacy measure — mirapex er ranks highest among Nonergot Dopamine Agonist drugs used for parkinson disease. Always consult a professional.
Which nonergot dopamine agonist drugs treat parkinson disease?
pharmaranks lists 3 Nonergot Dopamine Agonist products used for parkinson disease, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.